Selected Quarterly Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2012

Selected Quarterly Data (Unaudited) [Abstract]

Selected quarterly data

2012 Quarter Ended	Dec. 31			Sep. 30			June 30			Mar. 31
				(As Restated)			(As Restated)			(As Restated)
	(in thousands, except per share data)
Total revenue	$	13,983		$	10,262		$	15,697		$	17,229
Gross profit		4,754			2,839			4,807			4,406
Operating expenses (income) (including cost of product revenue, gain on sale of oilseed processing business and restructuring)—continuing operations (1)		17,229			15,066			18,067			(14,887	)
Net income (loss) attributed to Verenium Corporation		(3,622	)		(5,213	)		(2,253	)		29,301
Basic net income (loss) attributed to Verenium Corporation per common share		(0.28	)		(0.41	)		(0.18	)		2.32
Diluted net income (loss) attributed to Verenium Corporation per common share		(0.28	)		(0.41	)		(0.18	)		2.26

2011 Quarter Ended	Dec. 31			Sep. 30		June 30			Mar. 31
	(As Restated)			(As Restated)
	(in thousands, except per share data)
Total revenue—continuing operations	$	14,321		$	18,416	$	15,134		$	13,396
Gross profit		5,436			6,044		5,086			4,948
Operating expenses (including cost of product revenue)—continuing operations		16,911			16,060		16,428			18,054
Net income (loss) attributed to Verenium Corporation		(2,896	)		6,069		(1,468	)		3,813
Basic and diluted net income (loss) attributed to Verenium Corporation per common share		(0.23	)		0.48		(0.12	)		0.30

(1) Includes gain on sale of oilseed processing business of $31.3 million recorded in the first quarter of 2012.

Previously issued consolidated balance sheet

	Consolidated Balance Sheet September 30, 2012									Consolidated Balance Sheet June 30, 2012									Consolidated Balance Sheet March 31, 2012
	Previously Reported			Adjustments(1)			As Restated			Previously Reported			Adjustments(1)			As Restated			Previously Reported			Adjustments(1)			As Restated
	(in thousands)									(in thousands)									(in thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	13,938		$	0		$	13,938		$	14,357		$	0		$	14,357		$	58,559		$	0		$	58,559
Restricted cash		2,500			0			2,500			2,500			0			2,500			2,500			0			2,500
Accounts receivable, net		7,250			0			7,250			10,017			0			10,017			9,065			0			9,065
Inventories, net		5,017			0			5,017			5,483			0			5,483			6,946			0			6,946
Other current assets		2,700			(69	)		2,631			2,560			(104	)		2,456			3,101			(638	)		2,463
Total current assets		31,405			(69	)		31,336			34,917			(104	)		34,813			80,171			(638	)		79,533
Property and equipment, net		14,346			22,515			36,861			13,502			20,944			34,446			10,468			12,334			22,802
Restricted cash		1,600			0			1,600			3,200			0			3,200			3,200			0			3,200
Other long term assets		653			(384	)		269			692			(416	)		276			283			0			283
Total assets	$	48,004		$	22,062		$	70,066		$	52,311		$	20,424		$	72,735		$	94,122		$	11,696		$	105,818
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	4,517		$	0		$	4,517		$	5,597		$	0		$	5,597		$	9,232		$	0		$	9,232
Accrued expenses		4,363			79			4,442			5,341			106			5,447			6,127			99			6,226
Deferred revenue		1,806			0			1,806			1,813			0			1,813			2,037			203			2,240
Convertible debt, at face value		0			0			0			0			0			0			34,851			0			34,851
Other current liabilities		402			0			402			291			0			291			363			0			363
Total current liabilities		11,088			79			11,167			13,042			106			13,148			52,610			302			52,912
Long term debt, net of current portion		2,705			0			2,705			0			0			0			0			0			0
Lease financing obligation, net of current portion		0			21,352			21,352			0			19,962			19,962			0			11,357			11,357
Other long term liabilities		653			256			909			792			24			816			1,198			676			1,874
Total liabilities		14,446			21,687			36,133			13,834			20,092			33,926			53,808			12,335			66,143
Stockholders’ equity:
Common stock		13			0			13			13			0			13			12			0			12
Additional paid-in capital		612,007			535			612,542			611,669			536			612,205			611,028			(209	)		610,819
Accumulated deficit		(578,462	)		(160	)		(578,622	)		(573,205	)		(204	)		(573,409	)		(570,726	)		(430	)		(571,156	)
Total stockholders’ equity		33,558			375			33,933			38,477			332			38,809			40,314			(639	)		39,675
Total liabilities and stockholders’ equity	$	48,004		$	22,062		$	70,066		$	52,311		$	20,424		$	72,735		$	94,122		$	11,696		$	105,818

(1) Adjustments include impact of revisions to lease accounting as well as corrections for immaterial adjustments that were not reflected in the previously reported numbers. Additionally, certain reclassifications have been made to the consolidated balance sheet to conform to the current presentation as of December 31, 2012.

	Consolidated Balance Sheet September 30, 2011									Consolidated Balance Sheet June 30, 2011
	Previously Reported			Adjustments(1)			As Restated			Previously Reported			Adjustments(1)			As Restated
	(in thousands)									(in thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	35,672		$	0		$	35,672		$	44,620		$	0		$	44,620
Restricted cash		5,000			0			5,000			5,000			0			5,000
Accounts receivable, net		7,981			0			7,981			9,447			0			9,447
Inventories, net		5,948			0			5,948			5,649			0			5,649
Other current assets		2,715			0			2,715			2,508			0			2,508
Total current assets		57,316			0			57,316			67,224			0			67,224
Property and equipment, net		5,513			5,695			11,208			3,645			3,067			6,712
Restricted cash		0			0			0			0			0			0
Other long term assets		463			0			463			602			0			602
Total assets	$	63,292		$	5,695		$	68,987		$	71,471		$	3,067		$	74,538
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	4,566		$	0		$	4,566		$	5,316		$	0		$	5,316
Accrued expenses		5,572			59			5,631			5,387			16			5,403
Deferred revenue		3,894			0			3,894			3,499			0			3,499
Accrued restructuring		587			0			587			1,047			0			1,047
Convertible debt, at carrying value		34,851			0			34,851			48,242			0			48,242
Other current liabilities		458			145			603			549			38			587
Total current liabilities		49,928			204			50,132			64,040			54			64,094
Lease financing obligation, net of current portion		0			5,232			5,232			0			3,029			3,029
Other long term liabilities		980			(12	)		968			946			(16	)		930
Long term liabilities of discontinued operations		65			0			65			134			0			134
Total liabilities		50,973			5,424			56,397			65,120			3,067			68,187
Stockholders’ equity:
Common stock		12			0			12			12			0			12
Additional paid-in capital		610,139			0			610,139			609,969			0			609,969
Accumulated deficit		(597,832	)		271			(597,561	)		(603,630	)		0			(603,630	)
Total stockholders’ equity		12,319			271			12,590			6,351			0			6,351
Total liabilities and stockholders’ equity	$	63,292		$	5,695		$	68,987		$	71,471		$	3,067		$	74,538

(1) Adjustments include impact of revisions to lease accounting as well as corrections for immaterial adjustments that were not reflected in the previously reported numbers. Additionally, certain reclassifications have been made to the consolidated balance sheet to conform to the current presentation as of December 31, 2012.

Previously issued Consolidated Statements of Comprehensive Income

	Consolidated Statements  of Comprehensive Income Three Months Ended September 30, 2012									Consolidated Statements  of Comprehensive Income Three Months Ended June 30, 2012									Consolidated Statements  of Comprehensive Income Three Months Ended March 31, 2012
	Previously Reported			Adjustments(1)			As Restated			Previously Reported			Adjustments(1)			As Restated			Previously Reported			Adjustments(1)			As Restated
	(amounts in thousands, except per share data)									(amounts in thousands, except per share data)									(amounts in thousands, except per share data)
Revenue:
Product	$	8,004		$	0		$	8,004		$	12,242		$	0		$	12,242		$	11,721		$	0		$	11,721
Contract manufacturing		1,561			0			1,561			2,486			0			2,486			0			0			0
Collaborative and license		697			0			697			969			0			969			5,508			0			5,508
Total revenue		10,262			0			10,262			15,697			0			15,697			17,229			0			17,229
Operating (income) expenses:
Cost of product and contract manufacturing revenue		6,726			0			6,726			9,921			0			9,921			7,315			0			7,315
Research and development		4,045			(239	)		3,806			3,880			(47	)		3,833			3,161			0			3,161
Selling, general and administrative		4,783			(260	)		4,523			4,428			(124	)		4,304			5,928			(20	)		5,908
(Gain) loss on sale of oilseed processing business		0			0			0			203			(203	)		0			(31,481	)		203			(31,278	)
Restructuring charges		11			0			11			9			0			9			7			0			7
Total operating (income) expenses		15,565			(499	)		15,066			18,441			(374	)		18,067			(15,070	)		183			(14,887	)
Income (loss) from operations		(5,303	)		499			(4,804	)		(2,744	)		374			(2,370	)		32,299			(183	)		32,116
Other income and expenses:
Other income (expense), net		5			0			5			11			0			11			(341	)		(245	)		(586	)
Interest expense		(83	)		(440	)		(523	)		(54	)		(44	)		(98	)		(668	)		(26	)		(694	)
Gain (loss) on net change in fair value of derivative assets and liabilities		0			0			0			232			(93	)		139			(324	)		(382	)		(706	)
Total other income and (expenses), net		(78	)		(440	)		(518	)		189			(137	)		52			(1,333	)		(653	)		(1,986	)
Net income (loss) from continuing operations before income taxes		(5,381	)		59			(5,322	)		(2,555	)		237			(2,318	)		30,966			(836	)		30,130
Income tax (provision) benefit		147			(15	)		132			87			(11	)		76			(829	)		15			(814	)
Net income (loss) from continuing operations		(5,234	)		44			(5,190	)		(2,468	)		226			(2,242	)		30,137			(821	)		29,316
Net loss from discontinued operations		(23	)		0			(23	)		(11	)		0			(11	)		(15	)		0			(15	)
Net income (loss) attributed to Verenium Corporation	$	(5,257	)	$	44		$	(5,213	)	$	(2,479	)	$	226		$	(2,253	)	$	30,122		$	(821	)	$	29,301
Net income (loss) per share, basic:
Continuing operations	$	(0.41	)	$	0.00		$	(0.41	)	$	(0.20	)	$	0.02		$	(0.18	)	$	2.39		$	(0.07	)	$	2.33
Discontinued operations	$	0.00		$	0.00		$	0.00		$	0.00		$	0.00		$	0.00		$	0.00		$	0.00		$	0.00
Attributed to Verenium Corporation	$	(0.41	)	$	0.00		$	(0.41	)	$	(0.20	)	$	0.02		$	(0.18	)	$	2.39		$	(0.07	)	$	2.32
Net income (loss) per share, diluted:
Continuing operations	$	(0.41	)	$	0.00		$	(0.41	)	$	(0.20	)	$	0.02		$	(0.18	)	$	2.32		$	(0.06	)	$	2.26
Discontinued operations	$	0.00		$	0.00		$	0.00		$	0.00		$	0.00		$	0.00		$	0.00		$	0.00		$	0.00
Attributed to Verenium Corporation	$	(0.41	)	$	0.00		$	(0.41	)	$	(0.20	)	$	0.02		$	(0.18	)	$	2.32		$	(0.06	)	$	2.26
Shares used in calculating net income (loss) per share, basic		12,765			0			12,765			12,618			0			12,618			12,608			0			12,608
Shares used in calculating net income (loss) per share, diluted		12,765			0			12,765			12,618			0			12,618			13,192			(14	)		13,178
Comprehensive income (loss)	$	(5,257	)	$	44		$	(5,213	)	$	(2,479	)	$	226		$	(2,253	)	$	30,122		$	(821	)	$	29,301

(1) Adjustments include impact of revisions to lease accounting as well as corrections for immaterial adjustments that were not reflected in the previously reported numbers.

	Consolidated Statements of Comprehensive Income Three Months Ended December 31, 2011									Consolidated Statements of Comprehensive Income Three Months Ended September 30, 2011
	As Reported			Adjustments (1)			As Restated			As Reported			Adjustments (1)			As Restated
	(amounts in thousands, except per share data)									(amounts in thousands, except per share data)
Revenue:
Product	$	13,743		$	0		$	13,743		$	14,742		$	0		$	14,742
Collaborative and license		578			0			578			3,674			0			3,674
Total revenue		14,321			0			14,321			18,416			0			18,416
Operating expenses:
Cost of product and contract manufacturing revenue		8,307			0			8,307			8,698			0			8,698
Research and development		3,393			0			3,393			2,673			52			2,725
Selling, general and administrative		5,259			(51	)		5,208			4,940			(323	)		4,617
Restructuring charges		3			0			3			20			0			20
Total operating expenses		16,962			(51	)		16,911			16,331			(271	)		16,060
Income (loss) from operations		(2,641	)		51			(2,590	)		2,085			271			2,356
Other income and expenses:
Other income, net		5			0			5			7			0			7
Interest expense		(640	)		(26	)		(666	)		(625	)		0			(625	)
Gain on debt extinguishment upon repurchase of convertible notes		0			0			0			4,065			0			4,065
Gain on net change in fair value of derivative assets and liabilities		41			95			136			290			0			290
Total other income (expense), net		(594	)		69			(525	)		3,737			0			3,737
Net income (loss) from continuing operations before income taxes		(3,235	)		120			(3,115	)		5,822			271			6,093
Income tax benefit		368			0			368			0			0			0
Net income (loss) from continuing operations		(2,867	)		120			(2,747	)		5,822			271			6,093
Net loss from discontinued operations		(149	)		0			(149	)		(24	)		0			(24	)
Net income (loss) attributed to Verenium Corporation	$	(3,016	)	$	120		$	(2,896	)	$	5,798		$	271		$	6,069
Net income (loss) per share, basic:
Continuing operations	$	(0.23	)	$	0.01		$	(0.22	)	$	0.46		$	0.02		$	0.48
Discontinued operations	$	(0.01	)	$	0.00		$	(0.01	)	$	0.00		$	0.00		$	0.00
Attributed to Verenium Corporation	$	(0.24	)	$	0.01		$	(0.23	)	$	0.46		$	0.02		$	0.48
Net income (loss) per share, diluted:
Continuing operations	$	(0.23	)	$	0.01		$	(0.22	)	$	0.46		$	0.02		$	0.48
Discontinued operations	$	(0.01	)	$	0.00		$	(0.01	)	$	0.00		$	0.00		$	0.00
Attributed to Verenium Corporation	$	(0.24	)	$	0.01		$	(0.23	)	$	0.46		$	0.02		$	0.48
Shares used in calculating net income (loss) per share, basic		12,608			0			12,608			12,607			0			12,607
Shares used in calculating net income (loss) per share, diluted		12,608			0			12,608			12,607			0			12,607
Comprehensive income (loss)	$	(3,016	)	$	120		$	(2,896	)	$	5,798		$	271		$	6,069

(1) Adjustments include impact of revisions to lease accounting as well as corrections for immaterial adjustments that were not reflected in the previously reported numbers.

	Consolidated Statements of Comprehensive Income Nine Months Ended September 30, 2012									Consolidated Statements of Comprehensive Income Six Months Ended June 30, 2012
	Previously Reported			Adjustments (1)			As Restated			Previously Reported			Adjustments (1)			As Restated
	(amounts in thousands, except per share data)									(amounts in thousands, except per share data)
Revenue:
Product	$	31,967		$	0		$	31,967		$	23,963		$	0		$	23,963
Contract manufacturing		4,047			0			4,047			2,486			0			2,486
Collaborative and license		7,174			0			7,174			6,477			0			6,477
Total revenue		43,188			0			43,188			32,926			0			32,926
Operating (income) expenses:
Cost of product and contract manufacturing revenue		23,962			0			23,962			17,236			0			17,236
Research and development		11,086			(286	)		10,800			7,041			(47	)		6,994
Selling, general and administrative		15,139			(404	)		14,735			10,356			(144	)		10,212
Gain on sale of oilseed processing business		(31,278	)		0			(31,278	)		(31,278	)		0			(31,278	)
Restructuring charges		27			0			27			16			0			16
Total operating expenses		18,936			(690	)		18,246			3,371			(191	)		3,180
Income from operations		24,252			690			24,942			29,555			191			29,746
Other income and expenses:
Other expense, net		(325	)		(245	)		(570	)		(330	)		(245	)		(575	)
Interest expense		(805	)		(510	)		(1,315	)		(722	)		(70	)		(792	)
Loss on net change in fair value of derivative assets and liabilities		(92	)		(475	)		(567	)		(92	)		(475	)		(567	)
Total other expenses, net		(1,222	)		(1,230	)		(2,452	)		(1,144	)		(790	)		(1,934	)
Net income from continuing operations before income taxes		23,030			(540	)		22,490			28,411			(599	)		27,812
Income tax provision		(595	)		(11	)		(606	)		(742	)		4			(738	)
Net income from continuing operations		22,435			(551	)		21,884			27,669			(595	)		27,074
Net loss from discontinued operations		(49	)		0			(49	)		(26	)		0			(26	)
Net income attributed to Verenium Corporation	$	22,386		$	(551	)	$	21,835		$	27,643		$	(595	)	$	27,048
Net income per share, basic:
Continuing operations	$	1.77		$	(0.04	)	$	1.73		$	2.19		$	(0.05	)	$	2.15
Discontinued operations	$	0.00		$	0.00		$	0.00		$	0.00		$	0.00		$	0.00
Attributed to Verenium Corporation	$	1.77		$	(0.04	)	$	1.72		$	2.19		$	(0.05	)	$	2.14
Net income per share, diluted:
Continuing operations	$	1.75		$	(0.04	)	$	1.69		$	2.15		$	(0.05	)	$	2.11
Discontinued operations	$	0.00		$	0.00		$	0.00		$	0.00		$	0.00		$	0.00
Attributed to Verenium Corporation	$	1.74		$	(0.04	)	$	1.69		$	2.14		$	(0.05	)	$	2.11
Shares used in calculating net income per share, basic		12,664			0			12,664			12,614			0			12,614
Shares used in calculating net income per share, diluted		13,124			(181	)		12,943			13,117			(44	)		13,073
Comprehensive income	$	22,386		$	(551	)	$	21,835		$	27,643		$	(595	)	$	27,048

(1) Adjustments include impact of revisions to lease accounting as well as corrections for immaterial adjustments that were not reflected in the previously reported numbers.

	Consolidated Statements of Comprehensive Income Nine Months Ended September 30, 2011
	Previously Reported			Adjustments (1)			As Restated
	(amounts in thousands, except per share data)
Revenue:
Product	$	42,252		$	0		$	42,252
Collaborative and license		4,694			0			4,694
Total revenue		46,946			0			46,946
Operating expenses:
Cost of product and contract manufacturing revenue		26,174			0			26,174
Research and development		7,593			52			7,645
Selling, general and administrative		14,106			(323	)		13,783
Restructuring charges		2,940			0			2,940
Total operating expenses		50,813			(271	)		50,542
Income (loss) from operations		(3,867	)		271			(3,596	)
Other income and expenses:
Other income, net		50			0			50
Interest expense		(2,421	)		0			(2,421	)
Gain on debt extinguishment upon repurchase of convertible notes		15,349			0			15,349
Loss on net change in fair value of derivative assets and liabilities		(1,005	)		0			(1,005	)
Total other income, net		11,973			0			11,973
Net income from continuing operations		8,106			271			8,377
Net income from discontinued operations		37			0			37
Net income attributed to Verenium Corporation	$	8,143		$	271		$	8,414
Net income per share, basic:
Continuing operations	$	0.64		$	0.02		$	0.66
Discontinued operations	$	0.00		$	0.00		$	0.00
Attributed to Verenium Corporation	$	0.65		$	0.02		$	0.67
Net income per share, diluted:
Continuing operations	$	0.64		$	0.02		$	0.66
Discontinued operations	$	0.00		$	0.00		$	0.00
Attributed to Verenium Corporation	$	0.65		$	0.02		$	0.67
Shares used in calculating net income per share, basic		12,607			0			12,607
Shares used in calculating net income per share, diluted		12,607			0			12,607
Comprehensive income	$	8,143		$	271		$	8,414

(1) Adjustments include impact of revisions to lease accounting as well as corrections for immaterial adjustments that were not reflected in the previously reported numbers.

Previously issued Consolidated Statements of Cash Flows

	Consolidated Statement of Cash Flows Nine Months Ended September 30, 2012									Consolidated Statement of Cash Flows Six Months Ended June 30, 2012									Consolidated Statement of Cash Flows Three Months Ended March 31, 2012
	Previously Reported			Adjustments (1)			As Restated			Previously Reported			Adjustments (1)			As Restated			Previously Reported			Adjustments (1)			As Restated
	(in thousands)									(in thousands)									(in thousands)
Operating Activities:
Net income (loss)	$	22,386		$	(551	)	$	21,835		$	27,643		$	(595	)	$	27,048		$	30,122		$	(821	)	$	29,301
Net (income) loss from discontinued operations		49			0			49			26			0			26			15			0			15
Net income (loss) from continuing operations		22,435			(551	)		21,884			27,669			(595	)		27,074			30,137			(821	)		29,316
Adjustments to reconcile net income (loss) from continuing operations to net cash used in operating activities of continuing operations:
Depreciation and amortization		1,120			300			1,420			618			75			693			328			0			328
Share-based compensation		746			0			746			442			0			442			241			0			241
(Amortization) accretion of debt net premium/discount from convertible notes		73			0			73			73			0			73			73			0			73
Loss on net change in fair value of derivative assets and liabilities		92			475			567			92			475			567			324			382			706
Gain on sale of oilseed processing business		(31,278	)		0			(31,278	)		(31,278	)		0			(31,278	)		(31,481	)		203			(31,278	)
Non-cash restructuring charges		17			0			17			16			0			16			2			0			2
Change in operating assets and liabilities:
Accounts receivable		4,121			0			4,121			1,354			0			1,354			2,306			0			2,306
Inventories		1,306			0			1,306			840			0			840			(623	)		0			(623	)
Other assets		(548	)		583			35			(447	)		650			203			(578	)		767			189
Accounts payable and accrued liabilities		(6,204	)		1,020			(5,184	)		(4,248	)		304			(3,944	)		(2,244	)		91			(2,153	)
Deferred revenue		(2,545	)		0			(2,545	)		(2,291	)		0			(2,291	)		(1,815	)		0			(1,815	)
Net cash used in operating activities of continuing operations		(10,665	)		1,827			(8,838	)		(7,160	)		909			(6,251	)		(3,330	)		622			(2,708	)
Investing activities:
Proceeds from sale of oilseed processing business, net of transaction costs paid		31,183			0			31,183			31,183			0			31,183			33,733			0			33,733
Purchases of property and equipment, net		(7,684	)		(1,755	)		(9,439	)		(6,338	)		(890	)		(7,228	)		(3,014	)		(622	)		(3,636	)
Restricted cash		4,100			0			4,100			2,500			0			2,500			2,500			0			2,500
Net cash provided by (used in) investing activities of continuing operations		27,599			(1,755	)		25,844			27,345			(890	)		26,455			33,219			(622	)		32,597
Financing activities:
Principal payments on debt obligations		(34,851	)		0			(34,851	)		(34,851	)		0			(34,851	)		0			0			0
Proceeds from sale of common stock and warrants		481			0			481			447			0			447			6			0			6
Proceeds from issuance of debt, net of issuance costs		2,889			0			2,889			0			0			0			0			0			0
Lease financing obligation payments		0			(72	)		(72	)		0			(19	)		(19	)		0			0			0
Net cash used in financing activities of continuing operations		(31,481	)		(72	)		(31,553	)		(34,404	)		(19	)		(34,423	)		6			0			6
Cash used in discontinued operations:
Net cash used in operating activities of discontinued operations		(274	)		0			(274	)		(183	)		0			(183	)		(95	)		0			(95	)
Net cash used in discontinued operations		(274	)		0			(274	)		(183	)		0			(183	)		(95	)		0			(95	)
Net increase (decrease) in cash and cash equivalents		(14,821	)		0			(14,821	)		(14,402	)		0			(14,402	)		29,800			0			29,800
Cash and cash equivalents at beginning of year		28,759			0			28,759			28,759			0			28,759			28,759			0			28,759
Cash and cash equivalents at end of year	$	13,938		$	0		$	13,938		$	14,357		$	0		$	14,357		$	58,559		$	0		$	58,559
Supplemental disclosure of cash flow information:
Interest paid	$	958		$	555		$	1,513		$	958		$	80		$	1,038		$	0		$	0		$	0
Supplemental disclosure of non-cash activities:
Property acquired under lease financing obligation	$	0		$	14,293		$	14,293		$	0		$	12,551		$	12,551		$	0		$	3,927		$	3,927

(1) Adjustments include impact of revisions to lease accounting as well as corrections for immaterial adjustments that were not reflected in the previously reported numbers. The adjustments also correct amounts previously reflected as cash paid for equipment purchases related to its new facility, but for which the cash had not been paid as of the balance sheet date.

	Consolidated Statement of Cash Flows Nine Months Ended September 30, 2011
	Previously Reported			Adjustments(1)			As Restated
	(in thousands)
Operating Activities:
Net income	$	8,143		$	271		$	8,414
Net income from discontinued operations		(37	)		0			(37	)
Net income from continuing operations		8,106			271			8,377
Adjustments to reconcile net income from continuing operations to net cash used in operating activities of continuing operations:
Depreciation and amortization		1,017			0			1,017
Share-based compensation		1,058			0			1,058
Amortization of debt net premium/discount from convertible notes		(140	)		0			(140	)
Loss on extinguishment of debt		(15,349	)		0			(15,349	)
Loss on net change in fair value of derivative assets and liabilities		1,005			0			1,005
Non-cash restructuring charges		377			0			377
Change in operating assets and liabilities:
Accounts receivable		(1,273	)		0			(1,273	)
Inventories		(632	)		0			(632	)
Other assets		278			0			278
Accounts payable and accrued liabilities		(6,017	)		(955	)		(6,972	)
Deferred revenue		2,986			0			2,986
Net cash used in operating activities of continuing operations		(8,584	)		(684	)		(9,268	)
Investing activities:
Purchases of property and equipment, net		(3,916	)		684			(3,232	)
Net cash used in investing activities of continuing operations		(3,916	)		684			(3,232	)
Financing activities:
Repurchase of convertible debt		(38,645	)		0			(38,645	)
Net cash used in financing activities of continuing operations		(38,645	)		0			(38,645	)
Cash used in discontinued operations:
Net cash used in operating activities of discontinued operations		(1,112	)		0			(1,112	)
Net cash used in discontinued operations		(1,112	)		0			(1,112	)
Net decrease in cash and cash equivalents		(52,257	)		0			(52,257	)
Cash and cash equivalents at beginning of year		87,929			0			87,929
Cash and cash equivalents at end of year	$	35,672		$	0		$	35,672
Supplemental disclosure of cash flow information:
Interest paid	$	2,428		$	0		$	2,428
Supplemental disclosure of non-cash activities:
Property acquired under lease financing obligation	$	0		$	5,377		$	5,377

(1) Adjustments include impact of revisions to lease accounting as well as corrections for immaterial adjustments that were not reflected in the previously reported numbers.